MARSHALL WACE, LLP - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2021. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$1,542,653
+251.3%
1,574,136
+398.3%
0.00%
+200.0%
Q2 2023$439,141
-4.0%
315,929
+9.8%
0.00%0.0%
Q1 2023$457,292
-58.1%
287,605
+64.3%
0.00%
-50.0%
Q4 2022$1,090,393
-71.0%
175,023
-68.8%
0.00%
-75.0%
Q3 2022$3,758,000
+2123.7%
560,987
+2009.0%
0.01%
Q2 2022$169,000
-97.3%
26,600
-94.9%
0.00%
-100.0%
Q3 2021$6,268,000
-74.7%
520,095
-55.6%
0.03%
-76.8%
Q2 2021$24,789,000
-14.2%
1,172,070
+13.8%
0.11%
-15.2%
Q1 2021$28,882,000
-19.3%
1,029,701
-25.2%
0.13%
-32.0%
Q4 2020$35,774,000
-29.5%
1,375,930
+0.7%
0.19%
-40.3%
Q3 2020$50,778,000
-33.5%
1,366,105
-14.1%
0.32%
-39.3%
Q2 2020$76,336,000
+82.9%
1,590,774
+20.2%
0.54%
+28.3%
Q1 2020$41,744,000
+11121.5%
1,323,947
+14182.1%
0.42%
+20750.0%
Q1 2019$372,000
-62.7%
9,270
-23.9%
0.00%
-84.6%
Q2 2015$996,000
-90.7%
12,182
-89.5%
0.01%
-90.7%
Q1 2015$10,754,000
+4555.4%
116,138
+1932.9%
0.14%
+4566.7%
Q4 2014$231,0005,7130.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2021
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$20,735,0008.65%
Altium Capital Management LP 2,496,524$11,584,0003.88%
Deep Track Capital, LP 6,000,000$27,840,0001.78%
Paradigm Biocapital Advisors LP 1,157,246$5,370,0001.42%
Monaco Asset Management SAM 419,262$1,945,0000.77%
Rhenman & Partners Asset Management AB 981,582$4,555,0000.45%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$12,589,0000.39%
Bellevue Group AG 4,299,164$19,948,0000.23%
WASATCH ADVISORS LP 8,147,380$37,804,0000.19%
Telemetry Investments, L.L.C. 17,500$81,0000.13%
View complete list of ESPERION THERAPEUTICS INC NE shareholders